Kimberly Lounds Foster

Celgene

Corporate Vice President, Global Supply

Kimberly Lounds Foster is Corporate Vice President, Global Supply at Celgene, where she oversees Celgene’s Clinical and Commercial Supply Chain along with Commercial Manufacturing Operations.  Celgene develops and manufactures products on multiple technology platforms, including small molecules, biologics, and cell therapies. 

Prior to Celgene, Ms. Foster was Head of Global Supply Chain at Novartis’ Cell & Gene Therapy unit, where she was responsible for building out the commercial and clinical autologous supply chain for Kymriah (tisagenlecleucel), the first FDA-approved CAR T cell therapy. Ms. Foster held various positions at Sandoz, a Novartis company, where she built the External Supply Operations functions for the Americas and managed the Sandoz US supply chain for in-line products and new products launches and managed the warehouse and distributions network. 

Prior to Sandoz, Ms. Foster held various roles of increasing responsibilities at Catalent Pharma Solutions, Baxter Healthcare, Accenture and Merck. Ms. Foster’s diverse experience includes business development, mergers & acquisitions, management consulting, strategic planning, process engineering and operational excellence. 

Ms. Foster holds an M.B.A. from The Wharton School, University of Pennsylvania and a B.S. in chemical engineering from Northwestern University.